Jan. 2, 2009 -- Acura Pharmaceuticals, Inc. and King Pharmaceuticals, Inc. (NYSE:KG) today announced that Acura has submitted a New Drug Application for Acurox (oxycodone HCl/niacin) Tablets to the U.S. FDA including a request for priority review.
The details can be read here.
No comments:
Post a Comment